JPTL
2021-08-23
Great
Pfizer and BioNTech SE shares surged in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中飙升</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":835843645,"tweetId":"835843645","gmtCreate":1629706714387,"gmtModify":1631892318520,"author":{"id":3585350696038563,"idStr":"3585350696038563","authorId":3585350696038563,"authorIdStr":"3585350696038563","name":"JPTL","avatar":"https://static.tigerbbs.com/6f6dde4c2c1d83e8d80141b547948419","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Great</p></body></html>","htmlText":"<html><head></head><body><p>Great</p></body></html>","text":"Great","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/835843645","repostId":1104804215,"repostType":4,"repost":{"id":"1104804215","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629706373,"share":"https://www.laohu8.com/m/news/1104804215?lang=zh_CN&edition=full","pubTime":"2021-08-23 16:12","market":"us","language":"en","title":"Pfizer and BioNTech SE shares surged in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中飙升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1104804215","media":"Tiger Newspress","summary":"Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval","content":"<p>Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday,according to the New York Times.</p><p><blockquote>辉瑞和BioNTech SE股价在盘前交易中飙升。食品和药物管理局。据《纽约时报》报道，该公司的目标是在周一全面批准辉瑞的新冠疫苗。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7fdc37e9193346a16038693153dd045e\" tg-width=\"362\" tg-height=\"125\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.</p><p><blockquote>据知情人士透露，美国食品药品监督管理局正在推动周一批准辉瑞-BioNTech的两剂新冠肺炎疫苗，进一步加快了该疫苗许可的提前时间表。</blockquote></p><p> Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.</p><p><blockquote>监管机构正在努力在周五之前完成这一过程，但仍在完成大量文书工作并与该公司进行谈判。未获授权公开谈论该计划的知情人士警告说，如果审查的某些部分需要更多时间，批准可能会推迟到周一之后。</blockquote></p><p> An F.D.A. spokeswoman declined to comment.</p><p><blockquote>食品和药物管理局。发言人拒绝置评。</blockquote></p><p> The agency had recently set an unofficial deadline for approval of around Labor Day.</p><p><blockquote>该机构最近设定了一个非官方的批准截止日期，大约是劳动节。</blockquote></p><p> The approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting final regulatory action before putting in effect mandates. Federal and state health officials are also hoping that an approved vaccine will draw interest from some Americans who have been hesitant to take one that was only authorized for emergency use, a phenomenon suggested by recent polling.</p><p><blockquote>该批准预计将为公共和私人组织的一系列疫苗接种要求铺平道路，这些组织在实施授权之前正在等待最终监管行动。联邦和州卫生官员还希望获得批准的疫苗能够引起一些美国人的兴趣，他们一直犹豫是否要服用仅授权紧急使用的疫苗，最近的民意调查表明了这一现象。</blockquote></p><p> Some universities and hospitals are expected to mandate inoculation once a vaccine is fully approved. The Pentagon this month said it planned to make Covid vaccinations mandatory for the country’s 1.3 million active-duty troops “no later” than the middle of next month, or sooner if the F.D.A. acts earlier.</p><p><blockquote>一旦疫苗获得完全批准，一些大学和医院预计将强制接种。五角大楼本月表示，计划“不迟于”下个月中旬强制该国130万现役军人接种新冠疫苗，如果食品和药物管理局批准，则会更早。早些时候的行为。</blockquote></p><p> Once it obtains the approval, Pfizer-BioNTech is planning to quickly ask the F.D.A. to approve a third dose as a booster shot. The Biden administration on Wednesday announced that fully vaccinated adults should prepare to get booster shots eight months after they received their second doses, beginning Sept. 20. Pfizer is expected to finish submitting data that it says shows a third shot is safe and effective next week.</p><p><blockquote>一旦获得批准，辉瑞-BioNTech计划迅速询问食品和药物管理局。批准第三剂作为加强注射。拜登政府周三宣布，从9月20日开始，完全接种疫苗的成年人应在接种第二剂疫苗八个月后准备接种加强针。辉瑞预计将于下周完成提交数据，称这些数据显示第三次注射是安全有效的。</blockquote></p><p> The F.D.A. last week updated its authorizations of Pfizer-BioNTech’s and Moderna’s vaccines to allow third doses for some immunocompromised people, a decision backed by the Centers for Disease Control and Prevention.</p><p><blockquote>食品和药物管理局。上周更新了辉瑞BioNTech和Moderna疫苗的授权，允许一些免疫功能低下的人接种第三剂疫苗，这一决定得到了疾病控制和预防中心的支持。</blockquote></p><p> Regulators are still reviewing Moderna’s application for full approval for its coronavirus vaccine, and a decision could come at least several weeks after the one for Pfizer-BioNTech. Moderna is planning to submit its data in support of a booster shot in September.</p><p><blockquote>监管机构仍在审查Moderna全面批准其冠状病毒疫苗的申请，可能会在辉瑞-BioNTech做出决定至少几周后做出决定。Moderna计划在9月份提交支持加强注射的数据。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech SE shares surged in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中飙升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech SE shares surged in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中飙升</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-23 16:12</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday,according to the New York Times.</p><p><blockquote>辉瑞和BioNTech SE股价在盘前交易中飙升。食品和药物管理局。据《纽约时报》报道，该公司的目标是在周一全面批准辉瑞的新冠疫苗。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7fdc37e9193346a16038693153dd045e\" tg-width=\"362\" tg-height=\"125\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.</p><p><blockquote>据知情人士透露，美国食品药品监督管理局正在推动周一批准辉瑞-BioNTech的两剂新冠肺炎疫苗，进一步加快了该疫苗许可的提前时间表。</blockquote></p><p> Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.</p><p><blockquote>监管机构正在努力在周五之前完成这一过程，但仍在完成大量文书工作并与该公司进行谈判。未获授权公开谈论该计划的知情人士警告说，如果审查的某些部分需要更多时间，批准可能会推迟到周一之后。</blockquote></p><p> An F.D.A. spokeswoman declined to comment.</p><p><blockquote>食品和药物管理局。发言人拒绝置评。</blockquote></p><p> The agency had recently set an unofficial deadline for approval of around Labor Day.</p><p><blockquote>该机构最近设定了一个非官方的批准截止日期，大约是劳动节。</blockquote></p><p> The approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting final regulatory action before putting in effect mandates. Federal and state health officials are also hoping that an approved vaccine will draw interest from some Americans who have been hesitant to take one that was only authorized for emergency use, a phenomenon suggested by recent polling.</p><p><blockquote>该批准预计将为公共和私人组织的一系列疫苗接种要求铺平道路，这些组织在实施授权之前正在等待最终监管行动。联邦和州卫生官员还希望获得批准的疫苗能够引起一些美国人的兴趣，他们一直犹豫是否要服用仅授权紧急使用的疫苗，最近的民意调查表明了这一现象。</blockquote></p><p> Some universities and hospitals are expected to mandate inoculation once a vaccine is fully approved. The Pentagon this month said it planned to make Covid vaccinations mandatory for the country’s 1.3 million active-duty troops “no later” than the middle of next month, or sooner if the F.D.A. acts earlier.</p><p><blockquote>一旦疫苗获得完全批准，一些大学和医院预计将强制接种。五角大楼本月表示，计划“不迟于”下个月中旬强制该国130万现役军人接种新冠疫苗，如果食品和药物管理局批准，则会更早。早些时候的行为。</blockquote></p><p> Once it obtains the approval, Pfizer-BioNTech is planning to quickly ask the F.D.A. to approve a third dose as a booster shot. The Biden administration on Wednesday announced that fully vaccinated adults should prepare to get booster shots eight months after they received their second doses, beginning Sept. 20. Pfizer is expected to finish submitting data that it says shows a third shot is safe and effective next week.</p><p><blockquote>一旦获得批准，辉瑞-BioNTech计划迅速询问食品和药物管理局。批准第三剂作为加强注射。拜登政府周三宣布，从9月20日开始，完全接种疫苗的成年人应在接种第二剂疫苗八个月后准备接种加强针。辉瑞预计将于下周完成提交数据，称这些数据显示第三次注射是安全有效的。</blockquote></p><p> The F.D.A. last week updated its authorizations of Pfizer-BioNTech’s and Moderna’s vaccines to allow third doses for some immunocompromised people, a decision backed by the Centers for Disease Control and Prevention.</p><p><blockquote>食品和药物管理局。上周更新了辉瑞BioNTech和Moderna疫苗的授权，允许一些免疫功能低下的人接种第三剂疫苗，这一决定得到了疾病控制和预防中心的支持。</blockquote></p><p> Regulators are still reviewing Moderna’s application for full approval for its coronavirus vaccine, and a decision could come at least several weeks after the one for Pfizer-BioNTech. Moderna is planning to submit its data in support of a booster shot in September.</p><p><blockquote>监管机构仍在审查Moderna全面批准其冠状病毒疫苗的申请，可能会在辉瑞-BioNTech做出决定至少几周后做出决定。Moderna计划在9月份提交支持加强注射的数据。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104804215","content_text":"Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday,according to the New York Times.\n\nThe Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.\nRegulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.\nAn F.D.A. spokeswoman declined to comment.\nThe agency had recently set an unofficial deadline for approval of around Labor Day.\nThe approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting final regulatory action before putting in effect mandates. Federal and state health officials are also hoping that an approved vaccine will draw interest from some Americans who have been hesitant to take one that was only authorized for emergency use, a phenomenon suggested by recent polling.\nSome universities and hospitals are expected to mandate inoculation once a vaccine is fully approved. The Pentagon this month said it planned to make Covid vaccinations mandatory for the country’s 1.3 million active-duty troops “no later” than the middle of next month, or sooner if the F.D.A. acts earlier.\nOnce it obtains the approval, Pfizer-BioNTech is planning to quickly ask the F.D.A. to approve a third dose as a booster shot. The Biden administration on Wednesday announced that fully vaccinated adults should prepare to get booster shots eight months after they received their second doses, beginning Sept. 20. Pfizer is expected to finish submitting data that it says shows a third shot is safe and effective next week.\nThe F.D.A. last week updated its authorizations of Pfizer-BioNTech’s and Moderna’s vaccines to allow third doses for some immunocompromised people, a decision backed by the Centers for Disease Control and Prevention.\nRegulators are still reviewing Moderna’s application for full approval for its coronavirus vaccine, and a decision could come at least several weeks after the one for Pfizer-BioNTech. Moderna is planning to submit its data in support of a booster shot in September.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":411,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/835843645"}
精彩评论